Given that the AR signaling plays an essential role in the progression of PCa, ADT, like bicalutamide and abiraterone, has become the foundation for patients with locally advanced or metastatic PRAD (Lorente et al., 2015). This evidence concerns the gene AR and posterior cortical atrophy.